Vyvanse (lisdexamfetamine) is a prodrug, meaning it’s inactive when you swallow it and only becomes active after your body breaks it down. The conversion happens in your red blood cells, not your liver, which makes Vyvanse unusual among ADHD medications. Enzymes inside red blood cells split the drug into two pieces: dextroamphetamine, the active stimulant, and l-lysine, a naturally occurring amino acid your body already uses.
The Prodrug Design
Lisdexamfetamine is essentially a dextroamphetamine molecule with an amino acid (l-lysine) chemically bonded to it. That bond keeps the drug therapeutically inactive until it’s cleaved inside the body. You can think of it like a lock: the l-lysine attachment prevents the amphetamine from doing anything until the right enzymes cut it free. This design is intentional. It creates a built-in speed limit on how fast active amphetamine enters your system, which is why Vyvanse produces a smoother onset and longer duration than immediate-release stimulants.
Where the Conversion Happens
After you take Vyvanse, the intact prodrug is absorbed from your gastrointestinal tract into the bloodstream. The conversion to active dextroamphetamine does not happen in your stomach or intestines. Instead, it takes place inside red blood cells.
Specifically, enzymes in the cytosol (the interior fluid) of red blood cells are responsible for cleaving the bond between l-lysine and dextroamphetamine. Research published in Neuropsychiatric Disease and Treatment confirmed that this hydrolytic activity resides in red blood cell cytosol but not in the cell membrane fraction. The enzymes involved appear to be metallo-aminopeptidases, a class of enzymes that specialize in snipping amino acids off the end of peptide chains.
This is a key distinction from most other medications. The liver’s cytochrome P450 enzyme system, which processes the majority of drugs, is not involved in converting Vyvanse to its active form. That means Vyvanse has fewer drug interactions driven by liver metabolism and behaves more predictably across people who may process liver-dependent drugs at different speeds.
Timeline From Pill to Peak Effect
The prodrug itself is absorbed quickly. In clinical studies of a 60 mg dose, lisdexamfetamine reached its peak blood concentration in about 1 hour. But because the drug is inactive at that point, you don’t feel anything from the prodrug itself.
The active metabolite, dextroamphetamine, reaches its peak plasma concentration roughly 4.4 hours after the dose, with some individual variation (plus or minus about 1.2 hours). That gap between swallowing the pill and reaching peak active drug levels reflects the time it takes red blood cells to progressively convert the prodrug. It’s also the reason Vyvanse has a gradual ramp-up rather than a sudden hit.
The prodrug is cleared from your blood rapidly, with a plasma half-life averaging less than one hour. The active dextroamphetamine, however, lingers much longer. Dextroamphetamine’s half-life is generally around 10 to 12 hours, which is why a single morning dose of Vyvanse can provide symptom control that lasts into the evening.
Food and Stomach Acid Don’t Change the Process
Because the conversion happens in red blood cells rather than the gut, factors that commonly alter how other medications are absorbed have little effect on Vyvanse. Clinical pharmacokinetic studies showed that taking a proton pump inhibitor (which dramatically reduces stomach acid) alongside Vyvanse did not change the peak concentration, the time to peak concentration, or the total drug exposure of dextroamphetamine.
Changes in gastrointestinal transit time, the speed at which food moves through your digestive system, also don’t meaningfully alter the conversion. This is a practical advantage: you can take Vyvanse with or without food, and it performs consistently regardless of what you’ve eaten or what other medications might be changing your stomach pH.
What Happens After the Drug Is Active
Once dextroamphetamine is released from the prodrug, it behaves like any other amphetamine in the body. It increases the levels of dopamine and norepinephrine in the brain, which is how it improves focus, attention, and impulse control in people with ADHD.
The l-lysine that gets split off is simply an amino acid. Your body handles it the same way it handles the lysine you get from food (meat, eggs, legumes). It enters normal protein metabolism and poses no pharmacological effect.
Dextroamphetamine is eventually eliminated primarily through the kidneys. Some of it is excreted unchanged in urine, and some is further broken down before excretion. Urine pH can influence how quickly amphetamine is cleared: acidic urine speeds elimination, while alkaline urine slows it. This is why very high doses of vitamin C or acidic beverages are sometimes said to shorten the drug’s effects, though in practice, normal dietary variation rarely makes a clinically meaningful difference.
Why the Red Blood Cell Pathway Matters
The fact that Vyvanse relies on red blood cell enzymes rather than liver enzymes has several practical implications. First, it makes the drug’s release rate relatively consistent from person to person, since everyone has a large, steady supply of red blood cells performing the conversion. Second, it reduces the risk of drug-drug interactions. Medications that inhibit or induce liver enzymes (common antidepressants, antifungals, and many others) won’t speed up or slow down the activation of Vyvanse.
The enzyme-dependent conversion also creates a ceiling effect on how fast dextroamphetamine can be released, even if someone takes a very large dose. The red blood cell enzymes can only work so fast, so taking more of the drug extends the duration of active amphetamine in the blood more than it spikes the peak concentration. This is part of why Vyvanse is considered to have a lower potential for the intense rush associated with misuse of immediate-release amphetamines.